Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-22T19:12:47.387Z Has data issue: false hasContentIssue false
  • English
  • Français

Screening for Cognitive Impairment and Dementia in the Elderly

Published online by Cambridge University Press:  02 December 2014

Christopher J.S. Patterson  and
David A. Gass
Christopher J.S. Patterson
Affiliation:
Department of Medicine, McMaster University, Hamilton, ON, Canada
David A. Gass
Affiliation:
Department of Family Medicine, Dalhousie University, Halifax, NS, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

To review the evidence available to support or refute the recommendation to screen for cognitive impairment (cognitive deficits which do not affect daily function) and dementia in primary care.

Data Sources:

Medline search using terms listed at the end of this article; consultation with experts in the field; review of other published recommendations.

Study Selection:

There were no articles which described a randomized controlled trial of screening versus no screening. Studies were therefore chosen which aided in the definition; natural history; interventions and outcomes including possible negative effects.

Data Synthesis:

No systematic synthesis was performed. Background papers were circulated to a panel of experts prior to the Canadian Consensus Conference on Dementia and conclusions endorsed by consensus.

Conclusion:

1. There is insufficient evidence to recommend for or against screening for cognitive impairment or dementia. (C); 2. Memory complaints should be evaluated and the individual followed to assess progression. (B); 3. When caregivers or informants describe cognitive decline in an individual, these observations should be taken very seriously; cognitive assessment and careful follow-up are indicated. (A) (See Appendix).

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 28 , Supplement S1: Canadian Consensus Conference on Dementia , May 2001 , pp. S42 - S51
Copyright
Copyright © The Canadian Journal of Neurological 2001

References

References

1. Whitby, L. Screening for disease – definitions and criteria. Lancet 1974; 2: 819–821.CrossRefGoogle ScholarPubMed
2. Patterson, C, Gauthier, S, Bergman, H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can Med Assoc J 1999; 160 (Suppl 12): S1–S16.Google ScholarPubMed
3. Lezak, MD. Neuropsychological Assessment. New York. Oxford University Press. 1976;14.Google Scholar
4. Wilson, JMC, Jungner, G. Principles and Practice of Screening for Disease. Public Health Paper. No. 34. WHO. Geneva. 1968.Google Scholar
5. Canadian Study of Health & Aging Working Group. Canadian study of health & aging: study methods and prevalence of dementia. Can Med Assoc J 1994; 150(6): 899–913.Google Scholar
6. Canadian Study of Health & Aging Working Group. The incidence of dementia in Canada. Neurology 2000; 55: 66–73.CrossRefGoogle Scholar
7. Graham, JE, Rockwood, K, Beattie, B, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793–1796.CrossRefGoogle Scholar
8. Small, G, Ivnik, RJ, Petersen, RC, et al. Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. Psychol Aging 1991; 6: 551–558.Google Scholar
9. Reisberg, B, Ferris, S, DeLeon, M, Crook, T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136–1139.Google ScholarPubMed
10. Jorm, AF, Christensen, H, Korten, A, et al. Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol Med 1997; 27: 91–98. CrossRefGoogle ScholarPubMed
11. Jonker, C, Launer, LJ, Hooijer, C, Lindeboom, J. Memory complaints and memory impairment in older individuals. J Am Geriatr Soc 1996; 44: 44–49.CrossRefGoogle ScholarPubMed
12. Tobiansky, R, Blizard, R, Livingston, G, Mann, A. The Gospel Oak Study Stage IV: the clinical relevance of subjective memory impairment in older people. Psychol Med 1995; 25: 779–786.CrossRefGoogle ScholarPubMed
13. Hänninen, T, Reinikainen, KJ, Helkala, E-L, et al. Subjective memory complaints and personality traits in normal elderly subjects. J Am Geriatr Soc 1994; 42: 1–4.CrossRefGoogle ScholarPubMed
14. Christensen, H, Henderson, AS, Korten, AE, et al. ICD-10 Mild cognitive disorder: its outcome three years later. Int J Geriatr Psychiatr 1997; 12: 581–586.3.0.CO;2-B>CrossRefGoogle ScholarPubMed
15. Devenand, DP, Folz, M, Gorlyn, M, Moeller, JR, Stern, Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 1997; 45: 321–328.CrossRefGoogle Scholar
16. Petersen, RC. Mild cognitive impairment or questionable dementia? Arch Neurol 2000; 57: 643–644.CrossRefGoogle ScholarPubMed
17. Ritchie, K, Leibovici, D, Ledésert, B, Touchon, J. A typology of sub-clinical senescent cognitive disorder. Br J Psychiatr 1996; 168:470–476.CrossRefGoogle ScholarPubMed
18. Petersen, RC, Smith, GE, Waring, SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–308.CrossRefGoogle ScholarPubMed
19. Tierney, MC, Szalai, JP, Snow, WG, Fisher, RH. The prediction of Alzheimer’s disease. Arch Neurol 1996; 53: 423–427.CrossRefGoogle Scholar
20. Masur, DM, Sliwinski, M, Lipton, RB, Blau, AD, Crystal, HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427––1432.CrossRefGoogle ScholarPubMed
21. Folstein, MF, Folstein, SE, McHugh, PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.CrossRefGoogle Scholar
22. Braekus, A, Laake, K, Engedal, K. A low, “normal” score on the Mini-Mental State Examination predicts development of dementia after three years. J Am Geriatr Soc 1995; 43: 656–661.CrossRefGoogle Scholar
23. Ferrucci, L, Cecchi, F, Guralnik, JM, et al for the FINE Study Group. Does the clock drawing test predict cognitive decline in older persons independent of the Mini-Mental State Examination? J Am Geriatr Soc 1996; 44: 1326–1331.CrossRefGoogle Scholar
24. Schmand, B, Jonker, C, Hooijer, C, Lindeboom, J. Subjective memory complaints may announce dementia. Neurology 1996; 46: 121–125.CrossRefGoogle ScholarPubMed
25. Schofield, PW, Marder, K, Dooneief, G, et al. Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am J Psychiatry 1997; 154: 609–615.Google ScholarPubMed
26. Hogan, DB, Ebly, EM. Predicting who will develop dementia in a cohort of Canadian seniors. Can J Neurol Sci 2000; 27: 18–24.CrossRefGoogle Scholar
27. Petersen, RC, Smith, GE, Ivnik, RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA 1995; 273: 1274–1278.CrossRefGoogle ScholarPubMed
28. Tierney, MC, Szalai, JP, Snow, WG, et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996; 46: 149–154.CrossRefGoogle ScholarPubMed
29. Tierney, MC, Szalai, JP, Snow, WG, et al. Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996; 46: 661–665.CrossRefGoogle ScholarPubMed
30. Small, GW, La Rue, A, Komo, S, Kaplan, A, Mandelkern, MA. Predictors of cognitive change in middle-aged and older adults with memory loss. Am J Psychiatry 1995; 152: 1757–1764.Google ScholarPubMed
31. Jorm, AF, Christensen, H, Henderson, AS, et al. Cognitive complaints of cognitive decline in the elderly: a comparison of reports by subjects and informants in a community survey. Psychol Med 1994; 24: 365–374.CrossRefGoogle Scholar
32. Stern, Y, Gurland, B, Tatemichi, TK, et al. Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 1994; 271: 1004–1010.CrossRefGoogle ScholarPubMed
33. Clarfield, AM. The reversible dementias: do they reverse? Ann Intern Med 1988; 109: 476–486.CrossRefGoogle ScholarPubMed
34. Mittelman, MS, Ferris, SH, Shulman, E, Steinberg, G, Levin, B. A family intervention to delay nursing home placement of patients with Alzheimer ’sdisease: a randomized controlled trial. JAMA 1996; 276: 1725–1731.CrossRefGoogle Scholar
35. O’Connor, DW, Pollitt, PA, Brook, CPB, Reiss, BB, Roth, M. Does early intervention reduce the number of elderly people with dementia admitted to institutions for long term care? BMJ 1991; 302: 871–875.CrossRefGoogle ScholarPubMed
36. Mulnard, RA, Cotman, CW, Kawas, C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer ’sdisease: a randomized controlled trial. Alzheimer’s Disease Cooperative Study. JAMA 2000; 283(8): 1007–1015.CrossRefGoogle Scholar
37. Crook, TH, Tinklenberg, J, Yesavage, J, et al. Effects of phosphatidyl serine in age-associated memory impairment. Neurology 1991; 41: 644–649.CrossRefGoogle ScholarPubMed
38. Israel, L, Melac, M, Milinkevitch, D, et al. Drug therapy and memory training programs: a double-blind randomized trial of general geriatric patients with age-associated memory impairment. Int Psychogeriatr 1994; 6: 155–170.CrossRefGoogle Scholar
39. McEntee, WJ, Crook, TH, Jenkyn, LR, et al. Treatment of age-associated memory impairment with guanfacine. Psychopharm Bull 1991; 27: 41–46.Google ScholarPubMed
40. Rogers, SL, Friedhoff, LT and the Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US multicenter, randomized double-blind, placebo-controlled trial. Dementia 1996; 7: 293–303.Google Scholar
41. Rogers, SL, Farlow, MR, Doody, RS, Mohs, R, Friedhoff LT and the Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s Disease. Neurology 1998; 50: 136–145.CrossRefGoogle Scholar
42. Rösler, M, Anand, R, Cicin-Sain, A, et al on behalf of the B303 Exelon Study Group. Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomized controlled trial. Br Med J 1999; 318: 633–640.CrossRefGoogle Scholar
43. Nordberg, A, Svensson, A-L. Cholinesterase inhibitors in the treatment of Alzheimer’s disease. A comparison of tolerability and pharmacology. Drug Safety 1998; 19(6): 465–480.CrossRefGoogle ScholarPubMed
44. Hux, MJ, O’Brien, BJ, Iskedjian, M, et al. Relation between severity of Alzheimer ’s disease and costs of caring. Can Med Assoc J 1998; 159: 457–465.Google ScholarPubMed
45. Sano, M, Ernesto, C, Thomas, RG, et al. A controlled trial of selegiline, alpha tocopherol or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. N Eng J Med 1997; 336: 1216–1222.CrossRefGoogle ScholarPubMed
46. Flicker, L, Logiudice, D, Carlin, JB, Ames, D. The predictive value of dementia screening instruments in clinical populations. Int J Geriat Psychiatry 1997; 12: 203–209.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
47. Jorm, AF, Jacomb, PA. The informant questionnaire on cognitive decline in the elderly. (IQCODE). Socio-demographic correlates, reliability, validity, and some norms. Psychol Med 1989; 19: 1015–1022.CrossRefGoogle ScholarPubMed
48. Jorm, AF. Assessment of cognitive impairment and dementia using informant reports. Clin Psychol Rev 1996; 16.Google Scholar
49. Jorm, AF, Christensen, H, Henderson, AS, et al. Informant ratings of cognitive decline of elderly people: relationship to longitudinal change on cognitive tests. Age Ageing 1996; 25: 125–129.CrossRefGoogle ScholarPubMed
50. Jorm, AF. Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test. Alzheimer Dis Assoc Disord 1997; 11: 158–182.CrossRefGoogle ScholarPubMed
51. Barberger-Gateau, P, Commenges, D, Gagnon, M, et al. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc 1992; 40: 1129–1134.CrossRefGoogle ScholarPubMed
52. Tombaugh, TN, McIntyre, NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992; 40: 922–935.CrossRefGoogle ScholarPubMed
53. O’Connor, DW, Pollitt, PA, Treasure, FP, Brook, CPB, Reiss, BB. The influence of education, social class, and sex on Mini-Mental State Scores. Psychol Med 1989; 19: 771–776.CrossRefGoogle ScholarPubMed
54. Kittner, SJ, White, LR, Farmer, ME, et al. Methodological issues in screening for dementia: the problem of education adjustment. J Chronic Dis 1986; 39: 163–170.CrossRefGoogle ScholarPubMed
55. Bleeker, ML, Bolla-Wilson, K, Kawas, C, Agnew, J. Age-specific norms for the Mini-Mental State Examination. Neurology 1988; 38: 1565–1568.CrossRefGoogle Scholar
56. Tangalos, EG, Smith, GE, Ivnik, RJ, et al. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc 1996; 71: 829–837.CrossRefGoogle ScholarPubMed
57. Wind, AW, Schellevis, FG, Van Staveren, G, et al. Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. Int J Geriat Psychiatry 1997; 12: 101–108.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
58. Wells, JC, Keyl, PM, Chase, GA, et al. Discriminant validity of a reduced set of Mini-Mental State Examination items for dementia and Alzheimer’s disease. Acta Psychiatr Scand 1992; 86: 23–31.CrossRefGoogle ScholarPubMed
59. Feher, EP, Mahurin, RK, Doody, RS, et al. Establishing the limits of the Mini-Mental State. Examination of “Subtests”. Arch Neurol 1992; 49: 87–92.CrossRefGoogle ScholarPubMed
60. Cossa, FM, Sala, SD, Musicco, M, Spinnler, H, Ubezio, MC. Comparison of two scoring systems of the Mini-Mental State Examination as a screening test for dementia. J Clin Epidemiol 1997; 50(8): 961–965.CrossRefGoogle ScholarPubMed
61. Christensen, H, Hadzi-Pavlovic, D, Jacomb, P. The psychometric differentiation of dementia from normal aging. Psychol Assess 1991; 3: 147–155.CrossRefGoogle Scholar
62. Stuss, DT, Meiran, N, Guzman, DA, Lafleche, G, Willmer, J. Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests. Arch Neurol 1996 Oct; 53(10): 1033–1039.CrossRefGoogle Scholar
63. Malloy, PF, Cummings, JL, Coffey, CE, et al. Cognitive screening instruments in neuropsychiatry: a report of the committee on research of the American Neuropsychiatry Association. J Neuropsychiatry Clin Neurosci 1997; 9(2): 189–197.Google Scholar
64. Robertson, D, Rockwood, K, Stolee, P. A short mental status questionnaire. Can J Aging 1982; 1: 16–20.CrossRefGoogle Scholar
65. Worral, G, Moulton, N. Cognitive function: survey of elderly persons living at home in rural Newfoundland. Can Fam Physician 1993; 39: 772–777.Google Scholar
66. Pfeiffer, E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975; 23: 433–441.CrossRefGoogle Scholar
67. Callahan, CM, Hendrie, HC, Tierney, WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 1995; 122: 422–429.CrossRefGoogle ScholarPubMed
68. Evans, DA, Funkenstein, HH, Albert, MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons. JAMA 1989; 262: 2551–2556.CrossRefGoogle Scholar
69. Folstein, MF, Anthony, JC, Parhad, I, et al. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc 1985; 33: 228–235.CrossRefGoogle ScholarPubMed
70. Teng, EL, Chui, HC. The Modified Mini-Mental State (3 MS) Examination. J Clin Psychiatry 1987; 48: 314–318.Google Scholar
71. Ebly, EM, Hogan, DB, Parhad, IM. Cognitive impairment in the nondemented elderly. Arch Neurol 1995; 52: 612–619.CrossRefGoogle ScholarPubMed
72. Gale, CR, Martyn, CN, Cooper, C. Cognitive impairment and mortality in a cohort of elderly people. Br Med J 1996; 312: 608–611.CrossRefGoogle Scholar
73. Erkinjuntti, T, Ostbye, T, Steenhuis, R, Hachinski, V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337: 1667–1674.CrossRefGoogle ScholarPubMed
74. Marshall, KG. Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm. Can Med Assoc J 1996; 155(2): 169–176.Google ScholarPubMed
75. Lasoski, MC, Thelen, MH. Attitudes of older and middle aged persons towards mental health intervention. Gerontologist 1987; 27: 288–292.CrossRefGoogle Scholar
76. Hutchinson, B, Woodward, CA, Norman, GR, Abelson, J, Brown, JA. Provision of preventive care to unannounced standardized patients. Can Med Assoc J 1998; 158: 185–193.Google Scholar
77. Busch, C, Kozak, J, Elmslie, T. Screening for cognitive impairment in the elderly. Can Fam Physician 1997; 43: 1763–1768.Google Scholar
78. Tangalos, EG, Smith, GE, Ivnik, RJ, et al. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc 1996; 71: 829–837.CrossRefGoogle ScholarPubMed
79. Rubenstein, LV, Calkins, DR, Young, RT, et al. Improving patient function: a randomized trial of functional disability screening. Ann Intern Med 1989; 111: 836–842.CrossRefGoogle ScholarPubMed
80. US Preventive Services Task Force. Screening for dementia. In: Guide to Clinical Preventive Services 2nd Ed. Alexandria, Virginia: International Medical Publishing. 1996; 531–540.Google Scholar
81. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Goldbloom, R. ed. Ottawa. Canada Communication Group. 1994; 902–911.Google Scholar
82. Rubenstein, LV, Calkins, DR, Greenfield, S, et al. Health Status Assessment for Elderly Patients: Report of the Society of General Internal Medicine Task Force on Health Assessment. J Am Geriatr Soc 1989; 37: 562–569.CrossRefGoogle Scholar
83. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, D.C.: American Psychiatric Association, 1994.Google Scholar
84. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: World Health Organization. 1993.Google Scholar
85. Morris, JC, McManus, DQ. The neurology of aging: normal vs. pathological change. Geriatrics 1991; 46: 47–48.Google Scholar
86. Forstl, H, Hentschel, F, Sattel, H, et al. Age-associated memory impairment and early Alzheimer’s disease. Only time will tell the difference. Arzneimittelforschung 1995; 45: 394–397.Google ScholarPubMed
87. Larrabee, GJ, Crook, TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6: 95–104.CrossRefGoogle ScholarPubMed
88. Crook, T, Bartus, RT, Ferris, SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health Work Group. Devel Neuropsychol 1986; 2: 261–276.CrossRefGoogle Scholar
89. Kral, VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962; 86: 257–260.Google ScholarPubMed
90. Barker, A, Jones, R, Jennison, C. Aprevalence study of age-associated memory impairment. Br J Psychiatr 1995; 167: 642–648.CrossRefGoogle Scholar
91. Hänninen, T, Hallikainen, M, Koivisto, K, et al. A follow-up study of age-associated memory impairment neuropsychological predictors of dementia. J Am Geriatr Soc 1995; 43: 1007–1015.CrossRefGoogle ScholarPubMed
92. O’Brien, JT, Beats, B, Hill, K, et al. Do subjective memory complaints precede dementia? A three-year follow-up of patients with supposed “benign senescent forgetfulness”. Int J Geriatr Psychiatry 1992; 7: 481–486.CrossRefGoogle Scholar
93. Bowen, J, Teri, L, Lukull, W, et al. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349(9054): 763–765.CrossRefGoogle ScholarPubMed
94. Petersen, RC, Smith, GE, Waring, SC, et al. Aging memory and mild cognitive impairment. Int Psychogeriatr 1997; 9: Suppl 1: 65–69.CrossRefGoogle ScholarPubMed

Internet References

1. CMACPG Infobase: http://www.cma.ca/cpgs Google Scholar
2. National Library of Medicine for Clinical Practice Guidelines: http://text.nlm.nih.gov/ Google Scholar